30 closest matches · ranked by relevance
Health Literacy · Health Insurance · Health Services Accessibility
Primary: Knowledge — 6.0; 5.7; 5.5 Units on a scale
Gynecologic Cancer
Primary: Feasibility - Enrollment — 32 Participants
Hypertension · Stroke
Primary: Patient Activation Measure — 61.33; 60.86; 63.49; 57.45 units on a scale
Human Papillomavirus
Primary: Number of Participants Who Completed HPV Vaccine Series — 364; 344 Participants
Diabetes Mellitus
Primary: HgbA1c — 8.5; 8.5; 7.99; 8.2 percentage of glycated hemoglobin
Colorectal Cancer
Primary: Completion of Colorectal Cancer Screening Tests — 102; 142; 88; 122 Participants — p=.005
Healthy Volunteers
Primary: Change From Baseline to 90-day Follow-up in Self Reported Weekly Minutes of Exercise — 92.2; 37.5; 63.1; 60.0 minutes — p=0.0288
Problem Behavior
Primary: Averge of Aappropriate Communication Responses — 3.33 direct observation of 5-min sessions
Human Papillomavirus Vaccines · Adolescent Health Services
Primary: HPV Vaccination (≥1 Dose), 11-14 Year Olds at 12 Months — 3189; 3833; 4260 Participants
Type 1 Diabetes Mellitus
Primary: Hemoglobin A1c — 7.988; 8.025 A1c percentage
Immunization · Vaccination
Primary: Change in the Rate of Missed Vaccination Opportunities Among All Clinicians — 37063; 40764; 14932; 18343 Eligible visits (due for vaccine)
Chronic Disease · Neoplasm Metastasis · Lung Neoplasm
Primary: Depression Symptoms, Family (HADS-D) — 6.4; 6.5; 6.3; 5.9 score on a scale — p=0.688
Healthy
Primary: Change in Intentions to Take Antivirals for Pandemic Flu — 8.29; 8.16; 8.23; 8.35 score on a scale — p=>.05
Concussion, Brain
Primary: Change in Concussion Management Behaviors: Communication — 5.49; 6.71 Score on a scale — p=0.021
Human Papillomavirus Infection
Primary: Acceptability of Providing HPV Vaccination to Children and of the Proposed Communication Strategy to Support HPV Vaccination — 4.1 units on a scale
Automated Communication Tools · Complex Medical Patients
Primary: Medication Errors at Hospital Discharge — 645; 359 Errors
Medication Adherence
Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)
Improved Communication Between Clinician and Patient
Primary: Cardiologist Behavior as Measured by WISER (Writing, Immersive Experiences, Speaking, Ethical Communication, and Research) Assessment. — 11.95; 13.15 Number of…
Hypercholesterolemia · Coronary Artery Disease · Dyslipidemia
Primary: Comparative Outcomes: Intervention Group LDL Reduction Compared to Control Group LDL Reduction — 11.0; 11.1 % of patients with major LDL reduction — p=0.99
Heart Failure NYHA Class II · Heart Failure NYHA Class III · Heart Failure NYHA Class IV
Primary: Physician Overall Satisfaction With the We Chatt Intervention Based on the Post Clinician Survey — 57.4 score on a scale
HIV · Tuberculosis
Primary: Participants Initiating Antiretroviral Therapy (ART) Within 28 Days of Abnormal Result — 8; 89 Participants
Active Breast Cancer Treatment
Primary: Between-group Differences in Patient Complete Illness Understanding at 9-months — 42; 38; 21; 17 Participants — p=0.264
Breast Cancer
Primary: Feasibility of the Intervention Trial - Enrollment — 96.97 percent of eligible study candidates
Adult Solid Neoplasm · Lymphoma
Primary: Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology…
Cancer
Primary: Provider to Patient Communication Score — 1.0423; 1.0723 score on a scale
Diabetes Mellitus
Primary: Patients' Perceived Self-efficacy to Communicate — 22.11; 22.14; 23.44; 22.63 units on a scale
Smoking · Tobacco Dependence
Primary: Number of Patients Contacted for Quitline Enrollment — 273; 59 Participants — p=.05
Coronavirus
Primary: Incidence Rate for Knowledge Gaps: Control vs. Any Intervention — 0.085; 0.065 proportion of knowledge gaps
Human Papilloma Virus
Primary: Percent Change From Baseline in the Percentage of Participants With HPV Vaccine Initiation — 18.1; 3.9 Percent Change from Baseline
Hypertension
Primary: BP Measurement Change at Follow-up — 132; 133; 80; 78 mmHg